CSPC Pharmaceutical Group Limited (HKG:1093)
7.73
-0.09 (-1.15%)
Jun 27, 2025, 4:08 PM HKT
CSPC Pharmaceutical Group Employees
CSPC Pharmaceutical Group had 21,400 employees as of December 31, 2024. The number of employees decreased by 2,100 or -8.94% compared to the previous year.
Employees
21,400
Change (1Y)
-2,100
Growth (1Y)
-8.94%
Revenue / Employee
1.35M HKD
Profits / Employee
210.08K HKD
Market Cap
92.92B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 21,400 | -2,100 | -8.94% |
Dec 31, 2023 | 23,500 | -1,337 | -5.38% |
Dec 31, 2022 | 24,837 | 91 | 0.37% |
Dec 31, 2021 | 24,746 | 3,219 | 14.95% |
Dec 31, 2020 | 21,527 | 4,227 | 24.43% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
BeOne Medicines | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
Innovent Biologics | 5,659 |
JD Health International | 3,564 |
WuXi Biologics | 12,575 |
Sino Biopharmaceutical | 24,379 |
Akeso | 3,035 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
CSPC Pharmaceutical Group News
- 1 day ago - Medtide Launches Hong Kong IPO to Boost Weight-loss Business - Benzinga
- 14 days ago - AstraZeneca Inks China AI Research Deal For Chronic Diseases - NDTV
- 14 days ago - AstraZeneca Inks Research Pact With China's CSPC Pharmaceuticals Focused On AI-Driven Research, Valued Up To $5.33 Billion - Benzinga
- 15 days ago - AstraZeneca signs US$5 billion research deal with China’s CSPC - BNN Bloomberg
- 16 days ago - CSPC Pharma Pursues Licensing Deals After Lackluster Earnings - Benzinga
- 4 weeks ago - Chinese biotech’s mega drug-licensing deals with multinationals surge - South China Morning Post
- 8 months ago - CSPC Pharmaceutical Group Limited goes ex dividend tomorrow - Seeking Alpha
- 9 months ago - AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline - Benzinga